Dividends & Buybacks ·
On July 31, 2026, the Board of Directors approved a reverse stock split at a ratio of one-for-three
NIVFNewGenIvf Group Ltd
On July 31, 2026, the Board of Directors approved a reverse stock split at a ratio of one-for-three. The transaction becomes effective on September 1, 2026, with split-adjusted trading commencing that day under symbol NIVF and new CUSIP G0544E154. Outstanding Class A Ordinary Shares will decrease from approximately 6,307,870 to roughly 2,102,623. Fractional shares are consolidated into whole shares rather than cashed out. Convertible securities are adjusted by dividing share counts by three. NewGenIvf Group Limited operates in the fertility and reproductive health services industry.